A study to evaluate the safety and efficacy of transbronchial biopsy using the cryoprobe in Japanese

A study to evaluate the safety and efficacy of transbronchial biopsy using the cryoprobe in Japanese - CRYO study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022837

Enrollment

200

Registered

2016-06-23

Start date

2016-03-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Transbronchial biopsies using the cryoprobe is performed after regular forceps biopsies.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Suspected lung cancer based on chest CT 2. Age: 20-74 years 3. ECOG performance status 0-2 4. Adequate bone marrow, liver, renal and respiratory function 5. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Patients with serious complication 2. Patients with the possibility of pregnant women, breast-feeding or during pregnancy

Design outcomes

Primary

Measure	Time frame
adverse events rate	—

Countries

Japan

Contacts

Public ContactHibiki Udagawa

National Cancer Center Hospital East Depertment of Thoracic Oncology

hudagawa@east.ncc.go.jp04-7133-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026